BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24277375)

  • 1. Quantitative assessment of the association between XPC Lys939Gln polymorphism and cutaneous melanoma risk.
    Zhou L; Lu Y; Yang G; Wu J
    Tumour Biol; 2014 Feb; 35(2):1427-32. PubMed ID: 24277375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of XPC Polymorphisms with Cutaneous Malignant Melanoma Risk: Evidence from a Meta-Analysis.
    Asadian F; Niktabar SM; Ghelmani Y; Kargar S; Akbarian E; Emarati SA; Sadeghizadeh-Yazdi J; Neamatzadeh H
    Acta Medica (Hradec Kralove); 2020; 63(3):101-112. PubMed ID: 33002396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive assessment of the association of ERCC2 Lys751Gln polymorphism with susceptibility to cutaneous melanoma.
    Dong Y; Zhuang L; Ma W
    Tumour Biol; 2013 Apr; 34(2):1155-60. PubMed ID: 23494240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. XPC Lys939Gln polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis.
    Peng Q; Lao X; Tang W; Chen Z; Li R; Qin X; Li S
    Diagn Pathol; 2014 Jun; 9():120. PubMed ID: 24947936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of XPC polymorphisms and lung cancer risk: a meta-analysis.
    Jin B; Dong Y; Zhang X; Wang H; Han B
    PLoS One; 2014; 9(4):e93937. PubMed ID: 24736739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A meta-analysis of XPC Lys939Gln polymorphism and melanoma susceptibility.
    Jiang W; Zhang H; Chen QW; Xie S
    J Eur Acad Dermatol Venereol; 2016 Aug; 30(8):1327-31. PubMed ID: 26551988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. XPC Lys939Gln and Ala499Val polymorphisms in colorectal cancer susceptibility: a meta-analysis of case-control studies.
    Liu C; Yin Q; Ying M; Lin J; Li L; Jiao G; Wang M; Wang Y
    Mol Biol Rep; 2014 Feb; 41(2):1171-8. PubMed ID: 24385304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An association between XPC Lys939Gln polymorphism and the risk of bladder cancer: a meta-analysis.
    Zhang Y; Wang X; Zhang W; Gong S
    Tumour Biol; 2013 Apr; 34(2):973-82. PubMed ID: 23269608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current evidences on XPC polymorphisms and breast cancer susceptibility: a meta-analysis.
    Zheng W; Cong XF; Cai WH; Yang S; Mao C; Zou HW
    Breast Cancer Res Treat; 2011 Aug; 128(3):811-5. PubMed ID: 21318603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between XPC Lys939Gln gene polymorphism and urinary bladder cancer susceptibility: a systematic review and meta-analysis.
    Dou K; Xu Q; Han X
    Diagn Pathol; 2013 Jul; 8():112. PubMed ID: 23819639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of Lys939Gln and Ala499Val polymorphisms of the XPC gene with cancer susceptibility: a meta-analysis.
    He J; Shi TY; Zhu ML; Wang MY; Li QX; Wei QY
    Int J Cancer; 2013 Oct; 133(8):1765-75. PubMed ID: 23400628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. XPC gene polymorphisms contribute to bladder cancer susceptibility: a meta-analysis.
    Dai QS; Hua RX; Zeng RF; Long JT; Peng ZW
    Tumour Biol; 2014 Jan; 35(1):447-53. PubMed ID: 23918308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms of the XPC gene may contribute to the risk of head and neck cancer: a meta-analysis.
    Zhang Y; Li Z; Zhong Q; Zhou W; Chen X; Chen X; Fang J; Huang Z
    Tumour Biol; 2014 Apr; 35(4):3917-31. PubMed ID: 24338715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of associations between XPC polymorphisms and colorectal cancer: a meta-analysis.
    Wang G; Sun H; Liu Z; Huang R; Chen Y; Tang Q; Yu L; Jiang Z; Wang X
    J BUON; 2015; 20(3):770-4. PubMed ID: 26214629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between polymorphisms of the XPC gene and lung cancer susceptibility: a meta-analysis.
    Zhu ML; Hua RX; Zheng L
    Tumour Biol; 2014 Apr; 35(4):2931-9. PubMed ID: 24375193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current evidences on XPC polymorphisms and gastric cancer susceptibility: a meta-analysis.
    Peng Q; Chen Z; Lu Y; Lao X; Mo C; Li R; Qin X; Li S
    Diagn Pathol; 2014 May; 9():96. PubMed ID: 24886180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A meta-analysis of evidences on XPC polymorphisms and lung cancer susceptibility.
    Liu C; Yin Q; Hu J; Li L; Zhang Y; Wang Y
    Tumour Biol; 2013 Apr; 34(2):1205-13. PubMed ID: 23381646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the XPC (A2920C), XPF (T30028C), TP53 (Arg72Pro) and GSTP1 (Ile105Val) polymorphisms in the risk of cutaneous melanoma.
    Oliveira C; Rinck-Junior JA; Lourenço GJ; Moraes AM; Lima CS
    J Cancer Res Clin Oncol; 2013 Jul; 139(7):1199-206. PubMed ID: 23568549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in XPC gene and risk for prostate cancer.
    Said R; Bougatef K; Setti Boubaker N; Jenni R; Derouiche A; Chebil M; Ouerhani S
    Mol Biol Rep; 2019 Feb; 46(1):1117-1125. PubMed ID: 30552616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis.
    Li C; Hu Z; Liu Z; Wang LE; Strom SS; Gershenwald JE; Lee JE; Ross MI; Mansfield PF; Cormier JN; Prieto VG; Duvic M; Grimm EA; Wei Q
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2526-32. PubMed ID: 17164380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.